T Erler Selected Research

Plasminogen Activators (Plasminogen Activator)

1/2001

[Treatment of posthemorrhagic hydrocephalus with intraventricular administration of recombinant plasminogen activator (rt-PA) and dexamethasone--possible prevention of permanent shunt implantation?].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T Erler Research Topics

Disease

1	Respiratory Insufficiency (Respiratory Failure) 03/2008
1	Virus Diseases (Viral Diseases) 03/2008
1	Guillain-Barre Syndrome 03/2008
1	Neoplasms (Cancer) 12/2003
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2002
1	Body Weight (Weight, Body) 05/2002
1	Cerebral Hemorrhage 01/2001
1	Hematoma 01/2001
1	Hydrocephalus (Hydrocephaly) 01/2001
1	Intracranial Hypertension 01/2001

Drug/Important Bio-Agent (IBA)

1	antineoplaston A10 (A 10)IBA 03/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2003
1	Biomarkers (Surrogate Marker)IBA 12/2003
1	Surface-Active Agents (Surfactants)IBA 05/2002
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2001
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2001
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2001
1	Proteins (Proteins, Gene)FDA Link 01/2001

Therapy/Procedure

2	Critical Care (Surgical Intensive Care) 03/2008 - 01/2001
2	Therapeutics 12/2003 - 05/2002